Mednet Logo
HomeDermatology
Dermatology

Dermatology

Clinical insights on skin conditions, dermatologic procedures, and treatment approaches from practicing dermatologists.

Recent Discussions

What is your approach to tapering off rituximab in a patient with pemphigus who seems to be remission?

2 Answers

Mednet Member
Mednet Member
Dermatology · Duke University

When evaluating a patient in clinical remission, I think the decision to taper should be weighed in light of multiple variables, including the patient’s duration and severity of disease prior to remission, extent of previously failed therapies, tolerability of rituximab, and anti-desmoglein antibody...

What therapies do you recommend for preventing keloid recurrence after surgical resection?

3 Answers

Mednet Member
Mednet Member
Dermatology · Baylor College of Medicine

For earlobe keloids specifically, we have had reasonable results with a mixture of 40mg/ml triamcinolone mixed with 50mg/ml 5FU in a 1:1 ratio. This is injected day of keloid removal, then every 4 weeks for at least the first 6 months. No more than 0.1-0.3 mL per session. The treatments can be space...

What is your approach to young teenagers with acne who have extremely sensitive skin, cannot tolerate typical acne regimens, cannot tolerate oral antibiotics, and refuse Accutane?

1
3 Answers

Mednet Member
Mednet Member
Dermatology · University of Pennsylvania

The formulation of benzoyl peroxide encapsulated in silica shells is extremely well tolerated by sensitive-skinned individuals. I was involved in pre-approval studies and found it remarkably well tolerated in such patients.

What do you view as the optimal use and timing of cemiplimab in high risk CSCC?

2
3 Answers

Mednet Member
Mednet Member
Dermatology · George Washington University

Increasingly, neoadjuvant cemiplimab has become our preferred approach for many patients with resectable high-risk CSCC, and this is consistent with what several high-volume centers are now doing. The high pathologic response rates, durable recurrence-free survival in responders, and meaningful surg...

What is your approach for female patients with severe atopic dermatitis well controlled on Dupixent planning to conceive or already pregnant?

2
1 Answers

Mednet Member
Mednet Member
Dermatology · Case Western Reserve University

Based on published data, I have a few concerns. However, the clinical trials of Dupixent failed to study effects on learning and memory.IL-4 and IL-13 are known to be important for learning and memory in mice. IL-4-producing T cells accumulate in the meningeal spaces, and acute depletion of these ce...

How do you clinically and diagnostically distinguish stiff skin syndrome from scleroderma?

1
3 Answers

Mednet Member
Mednet Member
Rheumatology · Arthritis Associates

One other disease consideration that one should differentiate is diabetic cheiroarthropathy, or "diabetic stiff hand syndrome." These patients can see decreased extension of the digits (often referred to as "Prayer sign" changes) and thickening of the skin in the digits. This can be present in 50% o...

What's your therapeutic approach for patients with severe cystic acne who have a history of inflammatory bowel diseases?

1 Answers

Mednet Member
Mednet Member
Dermatology · Geisinger Commonwealth Medical College

Persons with IBD and severe cystic acne warrant therapy with Accutane. I have successfully treated several cases with no exacerbation of IBD, publishing a case report in 1985: Oral isotretinoin and inflammatory bowel disease.A more recent study reached a similar conclusion: Does taking isotretinoin ...

In patients treated with infliximab, do rates of immunogenicity vary based on underlying disease (RA, IBD, sarcoidosis, etc) and/or baseline disease activity?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Yes, rates of infliximab immunogenicity appear to vary based on underlying disease, with evidence showing higher rates for RA than IBD and spondyloarthritis, and tend to increase with higher baseline disease activity. Most patients tend to develop anti-drug antibodies within the first year, but this...

What is the current role for genetic profile testing (e.g. DecisionDx-SCC) in the treatment paradigm for cutaneous malignancies?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cleveland Clinic

This is a very cool test that has a lot of potential to help us make decisions in practice (full disclosure, I advise Castle and get research support from them, but am not directly compensated by them). The data published thus far shows that it is prognostic to predict nodal or distant mets. However...

How do you manage severe chronic scalp pruritus in older women when biopsies and exams show no primary skin disease and standard therapies fail?

3
1 Answers

Mednet Member
Mednet Member
Dermatology · University of Miami Health

I use gabaergic drugs like Pregabalin and Gabapentin in high doses up to 300 mg and 3600 mg, slowly tapering up as many of these cases are neuropathic. I use compounded topical KAL cream 10% ketamine, lidocaine 5, and amitriptyline 5, or foam formulation or pramoxine lotion bid or topical compounded...